Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...
Through personal stories and a research study on group drumming, Chester Freeman explores the reality of "chemo brain" and ...
The FDA approved Scancell's phase 3 trial of iSCIB1+ for advanced melanoma, focusing on progression-free survival as a ...
Kamath: Similar to the phase 3 HERIZON-GEA-01 trial, what’s really the overall theme of these is that we have to identify ...
The FDA accepted a supplemental biologics license application and granted priority review for Datroway for adults ...
Last week, the U.S. Food and Drug Administration (FDA) approved the use of Darzalex Faspro (daratumumab and ...
Sabari — editor-in-chief of CURE, assistant professor at NYU Grossman School of Medicine, and director of High Reliability Organization Initiatives at Perlmutter Cancer Center — discussed how various ...
Dr. Myron Czuczman highlighted the significance of the recent U.S. Food and Drug Administration (FDA) approval of Lymphir ...
Pets provide emotional support and comfort during challenging times, such as a cancer journey, by reducing stress and anxiety ...
CURE sat down with Dr. Kathie-Ann Joseph to discuss surgical advancements for individuals with breast cancer. CURE recently ...
“Exelixis Announces U.S. FDA Accepted the New Drug Application for Zanzalintinib in Combination with an Immune Checkpoint ...
New data from a phase 1b/2 clinical trial shows that a specific protein called CD47 can help predict how well the investigational drug evorpacept works for patients with metastatic breast cancer, ALX ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results